Cancer Stem Cells: a Metastasizing Menace!

Overview

Journal Cancer Med

Specialty Oncology

Date 2016 Jan 17

PMID 26773710

Citations 17

Authors

Saurabh Bandhavkar

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the leading causes of death worldwide, and is estimated to be a reason of death of more than 18 billion people in the coming 5 years. Progress has been made in diagnosis and treatment of cancer; however, a sound understanding of the underlying cell biology still remains an unsolved mystery. Current treatments include a combination of radiation, surgery, and/or chemotherapy. However, these treatments are not a complete cure, aimed simply at shrinking the tumor and in majority of cases, there is a relapse of tumor. Several evidences suggest the presence of cancer stem cells (CSCs) or tumor-initiating stem-like cells, a small population of cells present in the tumor, capable of self-renewal and generation of differentiated progeny. The presence of these CSCs can be attributed to the failure of cancer treatments as these cells are believed to exhibit therapy resistance. As a result, increasing attention has been given to CSC research to resolve the therapeutic problems related to cancer. Progress in this field of research has led to the development of novel strategies to treat several malignancies and has become a hot topic of discussion. In this review, we will briefly focus on the main characteristics, therapeutic implications, and perspectives of CSCs in cancer therapy.

Citing Articles

Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review).

Krolewska-Daszczynska P, Wendlocha D, Smycz-Kubanska M, Stepien S, Mielczarek-Palacz A Oncol Lett. 2022; 24(6):465.

PMID: 36406181 PMC: 9667454. DOI: 10.3892/ol.2022.13585.

A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer.

Lu Y, Lian L, Shen X, Li Y, Ji S, Wang W Transl Cancer Res. 2022; 10(1):174-183.

PMID: 35116249 PMC: 8798931. DOI: 10.21037/tcr-20-2622.

Targeting Cancer Stem Cells-A Renewed Therapeutic Paradigm.

Amey C, Karnoub A Oncol Hematol Rev. 2021; 13(1):45-55.

PMID: 33959299 PMC: 8098671. DOI: 10.17925/ohr.2017.13.01.45.

Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells.

Raymond A, Gao B, Girard L, Minna J, Gomika Udugamasooriya D Sci Rep. 2019; 9(1):14954.

PMID: 31628412 PMC: 6802198. DOI: 10.1038/s41598-019-51004-3.

Inflammation and Metabolism in Cancer Cell-Mitochondria Key Player.

Neagu M, Constantin C, Popescu I, Zipeto D, Tzanakakis G, Nikitovic D Front Oncol. 2019; 9:348.

PMID: 31139559 PMC: 6527883. DOI: 10.3389/fonc.2019.00348.

References

Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B . Targeting Notch to target cancer stem cells. Clin Cancer Res. 2010; 16(12):3141-52. PMC: 3008160. DOI: 10.1158/1078-0432.CCR-09-2823. View

Teng Y, Wang X, Wang Y, Ma D . Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun. 2010; 392(3):373-9. DOI: 10.1016/j.bbrc.2010.01.028. View

Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y . Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. 2012; 323(2):161-70. DOI: 10.1016/j.canlet.2012.04.004. View

Kondratyev M, Kreso A, Hallett R, Girgis-Gabardo A, Barcelon M, Ilieva D . Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer. Oncogene. 2011; 31(1):93-103. DOI: 10.1038/onc.2011.212. View

Naujokat C, Steinhart R . Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol. 2012; 2012:950658. PMC: 3516046. DOI: 10.1155/2012/950658. View

Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O . Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005; 37(7):766-70. DOI: 10.1038/ng1590. View

Singh A, Arya R, Maheshwari S, Singh A, Meena S, Pandey P . Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance. Int J Cancer. 2014; 136(9):1991-2000. DOI: 10.1002/ijc.28804. View

Fan X, Khaki L, Zhu T, Soules M, Talsma C, Gul N . NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells. 2009; 28(1):5-16. PMC: 2878196. DOI: 10.1002/stem.254. View

Nozawa H, Tadakuma T, Ono T, Sato M, Hiroi S, Masumoto K . Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma. Cancer Sci. 2006; 97(10):1115-24. PMC: 11158321. DOI: 10.1111/j.1349-7006.2006.00287.x. View

10.

Singh B, Fu J, Srivastava R, Shankar S . Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One. 2011; 6(11):e27306. PMC: 3210776. DOI: 10.1371/journal.pone.0027306. View

11.

Li L, Borodyansky L, Yang Y . Genomic instability en route to and from cancer stem cells. Cell Cycle. 2009; 8(7):1000-2. DOI: 10.4161/cc.8.7.8041. View

12.

Croce C . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10(10):704-14. PMC: 3467096. DOI: 10.1038/nrg2634. View

13.

Wu X, Chen H, Wang X . Can lung cancer stem cells be targeted for therapies?. Cancer Treat Rev. 2012; 38(6):580-8. DOI: 10.1016/j.ctrv.2012.02.013. View

14.

Bandhavkar S . Cancer stem cells: a metastasizing menace!. Cancer Med. 2016; 5(4):649-55. PMC: 4831283. DOI: 10.1002/cam4.629. View

15.

Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J . Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A. 2007; 104(41):16158-63. PMC: 2042178. DOI: 10.1073/pnas.0702596104. View

16.

Purton L, Scadden D . Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell. 2008; 1(3):263-70. DOI: 10.1016/j.stem.2007.08.016. View

17.

Lou H, Dean M . Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene. 2007; 26(9):1357-60. DOI: 10.1038/sj.onc.1210200. View

18.

Van Den Broeck A, Vankelecom H, Van Delm W, Gremeaux L, Wouters J, Allemeersch J . Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One. 2013; 8(9):e73968. PMC: 3775803. DOI: 10.1371/journal.pone.0073968. View

19.

Hage C, Rausch V, Giese N, Giese T, Schonsiegel F, Labsch S . The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death Dis. 2013; 4:e627. PMC: 3674365. DOI: 10.1038/cddis.2013.158. View

20.

Wang Z, Li Y, Banerjee S, Sarkar F . Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res. 2009; 28(6A):3621-30. View